Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03242538 · ClinicalTrials.gov registry record · NA

Prehabilitation for Pelvic Cancer: Changes in Setup Variability

A NA study of Pelvic Cancer, sponsored by University of Massachusetts, Worcester.

Completed
Registry status
NA
Development phase
9
Enrollment target
1
Study location

NCT03242538: Completed NA study of Pelvic Cancer, sponsored by University of Massachusetts, Worcester.

NCT03242538 is a NA study of Pelvic Cancer that has completed, run by University of Massachusetts, Worcester. The registered enrollment target is 9 participants, below the 67-participant average among 6 other Pelvic Cancer trials with a reported enrollment target (87% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03242538, a NA study of Pelvic Cancer, has completed, sponsored by University of Massachusetts, Worcester.

COMPLETED
Registry status
NA
Development phase
9 participants
Enrollment target
1
Study location

Study Summary

The investigators hypothesize that two pelvic relaxation exercises will be feasible and safe to perform by subjects daily before radiation during the participant's treatment and will decrease variability of sacral slope measurements on daily port films. The investigators will observe trends in the daily variability and change in the sacral slope in each participant to determine if this could decrease variability. The investigators will compare these measurements to a retrospective cohort that did not have the exercises, but did demonstrate variability. Reducing set-up variability (which inadvertently occurs during radiation) is important to improve radiation targets and diminish potential adverse effects. The investigators will query participants for objective and subjective feedback on the exercises and record frequency and duration of the two exercises.

Primary Outcome

Reduced variation in sacral slope angle measured on daily port films.

Conditions Studied

Interventions

  • BEHAVIORAL Pelvic Exercise

Study Locations (1)

Massachusetts

  • University of Massachusetts Medical School - Worcester

Trial Details

FieldValue
Enrollment Target 9 participants
Start Date 2017-06-23
Est. Completion 2019-01-17
Phase NA

What the finished NCT03242538 record still lists

NCT03242538 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 9 participants, a relatively small participant target, below the 67-participant average among 6 other Pelvic Cancer trials with a reported enrollment target (87% lower).

The record links to 1 condition, with Pelvic Cancer appearing as the primary indexed condition, and to 1 intervention - of which Pelvic Exercise is the first listed.

NCT03242538 reports a single indexed study location in Massachusetts.

Frequently Asked Questions

What is clinical trial NCT03242538 about?

NCT03242538 is a clinical study titled "Prehabilitation for Pelvic Cancer: Changes in Setup Variability". The investigators hypothesize that two pelvic relaxation exercises will be feasible and safe to perform by subjects daily before radiation during the participant's treatment and will decrease variability of sacral slope measurements on daily port films. The investigators will observe trends in the d...

What is the current status of trial NCT03242538?

This trial is currently completed. It is a NA study. The enrollment target is 9 participants. The study started on 2017-06-23. Estimated completion is 2019-01-17.

What conditions does trial NCT03242538 study?

This clinical trial studies the following conditions: Pelvic Cancer.

What interventions are being tested in trial NCT03242538?

The interventions under investigation include: Pelvic Exercise (BEHAVIORAL).

Who is sponsoring clinical trial NCT03242538?

This trial is sponsored by University of Massachusetts, Worcester, which has 240 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03242538 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Pelvic Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03242538, the US trial registry maintained by the National Library of Medicine. NCT03242538 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.